Ledger.Open graph →
SEC Form D · filed March 7, 2025

NRX Pharmaceuticals, Inc

Offering
$3.5M
Sold
$3.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WILMINGTON, DE
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Michael Taylor · BONITA SPRINGS, FLDirectorJonathan Javitt · Wilmington, DEExec · DirectorPatrick Flynn · Concord, MADirectorMichael Abrams · Omaha, NEExecMichael Taylor · Cambridge, MADirectorChaim Hurvitz · Tel Aviv, L3DirectorDennis Mcbride · Wilmington, DEDirectorJonathan Javitt · Wilmington, DEExec · DirectorPatrick Flynn · Burlington, MADirectorMichael Abrams · Orem, UTExecMichael Taylor · Washiington, Washington, D.C.DirectorChaim Hurvitz · Stratford-upon-Avon, United KingdomDirectorDennis Mcbride · Wilmington, DEDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗